Erdös Eg

684 total citations
18 papers, 553 citations indexed

About

Erdös Eg is a scholar working on Genetics, Pharmacology and Molecular Biology. According to data from OpenAlex, Erdös Eg has authored 18 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Erdös Eg's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Apelin-related biomedical research (4 papers) and Peptidase Inhibition and Analysis (3 papers). Erdös Eg is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Apelin-related biomedical research (4 papers) and Peptidase Inhibition and Analysis (3 papers). Erdös Eg collaborates with scholars based in United States. Erdös Eg's co-authors include R Defendini, L. Maximilian Buja, F Alhenc‐Gelas, Johnson Rl, Rajko Igić, Tohru Nakajima, Kent M. Sorrells, Marin Sekosan, Genichiro Oshima and Isao Miwa and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Erdös Eg

18 papers receiving 504 citations

Peers

Erdös Eg
Arthur S. Brecher United States
J. J. Lanzillo United States
Thomas A. Morinelli United States
J.W.N. Akkerman Netherlands
F. Dol France
Eduardo Mascareno United States
Petra Quass Germany
Arthur S. Brecher United States
Erdös Eg
Citations per year, relative to Erdös Eg Erdös Eg (= 1×) peers Arthur S. Brecher

Countries citing papers authored by Erdös Eg

Since Specialization
Citations

This map shows the geographic impact of Erdös Eg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erdös Eg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erdös Eg more than expected).

Fields of papers citing papers by Erdös Eg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erdös Eg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erdös Eg. The network helps show where Erdös Eg may publish in the future.

Co-authorship network of co-authors of Erdös Eg

This figure shows the co-authorship network connecting the top 25 collaborators of Erdös Eg. A scholar is included among the top collaborators of Erdös Eg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erdös Eg. Erdös Eg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sekosan, Marin, et al.. (1998). Detection of neutral endopeptidase 24.11 (neprilysin) in human hepatocellular carcinomas by immunocytochemistry.. PubMed. 17(5A). 3233–8. 26 indexed citations
2.
Eg, Erdös & Isao Miwa. (1990). Effect of endotoxin shock on the plasma kallikrein-kinin system of the rabbit.. PubMed. 27(1). 92–5. 7 indexed citations
3.
Buja, L. Maximilian, et al.. (1988). Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney.. PubMed. 59(6). 789–97. 92 indexed citations
4.
Eg, Erdös, et al.. (1987). Human renal angiotensin I converting enzyme and neutral endopeptidase.. PubMed. 20. S45–8. 35 indexed citations
5.
Eg, Erdös, et al.. (1985). Neutral metalloendopeptidase in human male genital tract. Comparison to angiotensin I-converting enzyme.. PubMed. 52(4). 437–47. 90 indexed citations
6.
Alhenc‐Gelas, F, et al.. (1983). Measurement of human converting enzyme level by direct radioimmunoassay.. PubMed. 101(1). 83–96. 66 indexed citations
7.
Yamada, Kiyoshi & Erdös Eg. (1983). Isolation of two forms of kallikreins from rat kidney.. PubMed. 156. 387–91. 1 indexed citations
8.
Eg, Erdös. (1979). Enzyme inhibitors of the kallikrein and renin systems: introduction.. PubMed. 38(13). 2751–2. 4 indexed citations
9.
Eg, Erdös. (1979). Inhibitors of kininases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(13). 2774–7. 10 indexed citations
10.
Eg, Erdös, et al.. (1979). Inhibition of kininase II (angiotensin I converting enzyme) by human serum albumin and its fragments.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 120B. 477–85. 5 indexed citations
11.
Eg, Erdös, et al.. (1979). Angiotensin I converting enzyme (kininase II) in human endothelial cells in culture.. PubMed. 120B. 287–95. 8 indexed citations
12.
Eg, Erdös. (1977). The angiotensin I converting enzyme.. PubMed. 36(5). 1760–5. 106 indexed citations
13.
Igić, Rajko, et al.. (1977). [Activity of renin and angiotensin I converting enzyme in retina and ciliary body (author's transl)].. PubMed. 99(8). 482–4. 4 indexed citations
14.
Eg, Erdös & Genichiro Oshima. (1974). The angiotensin I converting enzyme of the lung and kidney.. PubMed. 24(5). 507–14. 7 indexed citations
15.
Igić, Rajko, et al.. (1972). Angiotensin I converting enzyme of the lung.. PubMed. 31(9). Suppl 2:51–61. 75 indexed citations
16.
Eg, Erdös, et al.. (1966). The effects of ATP and a proteolytic enzyme inhibitor in irreversible shock.. PubMed. 59(8). 467–71. 1 indexed citations
17.
Eg, Erdös, et al.. (1959). Inhibition of human cholinesterases by narcotics, analgesics and their antagonists.. PubMed. 120. 286–91. 8 indexed citations
18.
Eg, Erdös, et al.. (1958). The inhibitory effect of chlorpromazine and chlorpromazine sulfoxide on human cholinesterases.. PubMed. 117(1-2). 163–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026